aspartic acid has been researched along with Bile Duct Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, X; Bay, A; Cao, K; Chen, H; Gao, JS; Hildebrand, G; Huang, CK; Ji, C; Liu, D; Lu, S; Mueller, W; Mulla, J; Nagaoka, K; Nisar, MA; Setoyama, H; Tanaka, Y; Wands, JR | 1 |
1 other study(ies) available for aspartic acid and Bile Duct Cancer
| Article | Year |
|---|---|
Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase.
Topics: Aspartic Acid; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; DNA Damage; Humans; Ketoglutaric Acids; Mixed Function Oxygenases | 2024 |